[Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Progrès en urologie (Paris)

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 12703348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The natural history of small renal masses

  2005cited by this paper
• p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma

  2004cited by this paper
• Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas

  2004cited by this paper
• Cadherin-6 gene expression in conventional renal cell carcinomas: implication for detection of circulating renal cancer cells

  2002cited by this paper
• Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

  2002cited by this paper
• Expression of human mucin genes in normal kidney and renal cell carcinoma

  2002cited by this paper
• MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis.

  2002cited by this paper
• The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.

  2002cited by this paper
• Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

  2001cited by this paper
• Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.

  2001cited by this paper
• Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation

  2001cited by this paper
• Acquisition of Resistance to Fas-Mediated Apoptosis by Overexpression of Clusterin in Human Renal-Cell Carcinoma Cells

  2001cited by this paper
• Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases

  2001cited by this paper
• CD44s and CD44v6 expression in localized T1–T2 conventional renal cell carcinomas

  2001cited by this paper
• The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation

  2001cited by this paper
• Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

  2001cited by this paper
• Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

  2001cited by this paper
• Mass spectrometry meets chip technology: A new proteomic tool in cancer research?

  2001cited by this paper
• Calpain Function in the Modulation of Signal Transduction Molecules

  2001cited by this paper
• The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis

  2001cited by this paper
• Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.

  2001cited by this paper
• Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation

  2001cited by this paper
• Pax-2 expression in adult renal tumors.

  2001cited by this paper
• Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15)

  2001cited by this paper
• Diagnosing Primary and Metastatic Renal Cell Carcinoma: The Use of the Monoclonal Antibody `Renal Cell Carcinoma Marker'

  2001cited by this paper
• Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.

  2001cited by this paper
• The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.

  2001cited by this paper
• DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma

  2001cited by this paper
• Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.

  2001cited by this paper
• beta-catenin expression and mutational analysis in renal cell carcinomas.

  2000cited by this paper
• Flow cytometric analysis of antigen expression in malignant and normal renal cells.

  2000cited by this paper
• Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion.

  2000cited by this paper
• Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.

  2000cited by this paper
• Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.

  2000cited by this paper
• FISH analysis in chromophobe renal‐cell carcinoma

  2000cited by this paper
• Soluble Fas in serum from patients with renal cell carcinoma.

  2000cited by this paper
• Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.

  2000cited by this paper
• Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.

  2000cited by this paper
• Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions

  2000cited by this paper
• Renal lesions in von Hippel–Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins

  2000cited by this paper
• Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ‐confined renal cell carcinoma

  2000cited by this paper
• The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

  2000cited by this paper
• Utility of Cytokeratin 7 for Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma

  2000cited by this paper
• Expression of VCAM‐1, ICAM‐1, E‐ and P‐selectin and tumour‐associated macrophages in renal cell carcinoma

  2000cited by this paper
• The natural history of small renal masses.

  2000cited by this paper
• HER‐2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA‐A2.1‐restricted cytotoxic T lymphocytes

  2000cited by this paper
• Classical cadherins in urological cancers.

  2000cited by this paper
• Vinculin: Its Possible Use as a Marker of Normal Collecting Ducts and Renal Neoplasms with Collecting Duct System Phenotype

  2000cited by this paper
• Alterations in Expression of Cadherin–6 and E–Cadherin during Kidney Development and in Renal Cell Carcinoma

  2000cited by this paper
• Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes.

  2000cited by this paper
• Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.

  2000cited by this paper
• A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

  2000cited by this paper
• Molecular cytogenetics of t(X;1)(p11.2;q21) with complex rearrangements in a renal cell carcinoma.

  2000cited by this paper
• Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.

  2000cited by this paper
• Tiam1 mutations in human renal‐cell carcinomas

  2000cited by this paper
• CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma.

  1999cited by this paper
• Urokinase plasminogen activator: A prognostic marker in multiple types of cancer

  1999cited by this paper
• [Detection of circulating prostatic cells with RT-PCR PSA in prostatic cancer].

  1999cited by this paper
• Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

  1999cited by this paper
• Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

  1999cited by this paper
• Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys.

  1999cited by this paper
• Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell Carcinoma

  1999cited by this paper
• Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.

  1999cited by this paper
• Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor

  1999cited by this paper
• CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo

  1999cited by this paper
• Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.

  1999cited by this paper
• Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma.

  1999cited by this paper
• Expression of apoptotic regulatory molecules in renal cell carcinoma: Elevated expression of Fas ligand

  1999cited by this paper
• The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library.

  1999cited by this paper
• MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

  1999cited by this paper
• High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

  1999cited by this paper
• The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.

  1999cited by this paper
• The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9

  1999cited by this paper
• Detection of Prostate-Specific Antigen- or Prostate-Specific Membrane Antigen-Positive Circulating Cells in Prostatic Cancer Patients: Clinical Implications

  1999cited by this paper
• Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.

  1999cited by this paper
• Evaluation of apoptosis of tumor and of apparently normal cells in human renal carcinoma.

  1999cited by this paper
• MN/CA9 gene expression as a potential biomarker in renal cell carcinoma

  1999cited by this paper
• Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.

  1999cited by this paper
• Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.

  1999cited by this paper
• Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients

  1999cited by this paper
• CD44 is an independent prognostic factor in conventional renal cell carcinomas.

  1999cited by this paper
• Molecular expression of PSMA mRNA and protein in primary renal tumors

  1999cited by this paper
• Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type

  1999cited by this paper
• Differential expression and function of cadherin-6 during renal epithelium development.

  1998cited by this paper
• Transcript levels of aquaporin 1 and carbonic anhydrase IV as predictive indicators for prognosis of renal cell carcinoma patients after nephrectomy

  1998cited by this paper
• Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.

  1998cited by this paper
• Proliferation markers in tumours: interpretation and clinical value.

  1998cited by this paper
• nm23 protein expression in renal cell tumors: the role of the cell type.

  1998cited by this paper
• Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.

  1998cited by this paper
• Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

  1998cited by this paper
• Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms.

  1998cited by this paper
• Expression patterns of the ectopeptidases aminopeptidase N/CD13 and dipeptidyl peptidase IVICD26: immunoultrastructural topographic localization on different types of cultured cells

  1998cited by this paper
• Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP‐increasing mediators

  1998cited by this paper
• Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers.

  1998cited by this paper
• Detection of apoptotic cells in cytology specimens: An application of TdT‐mediated dUTP‐biotin nick end labeling to cell smears

  1998cited by this paper
• Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.

  1998cited by this paper
• Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.

  1997cited by this paper
• Pathologic findings at the time of nephrectomy for renal mass

  1997cited by this paper
• Soluble CD44 variants in the serum of patients with urological malignancies.

  1997cited by this paper
• Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma.

  1997cited by this paper

• Theranostics in Renal Cell Carcinoma—A Step Towards New Opportunities or a Dead End—A Systematic Review

  2024cites this paper
• Case Report: Early 68Ga-PSMA-PET Metabolic Assessment and Response to Systemic Treatment for First-Line Metastatic Clear Cell Renal Cell Carcinoma; About Two Clinical Cases

  2021cites this paper
• The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma

  2019cites this paper
• Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour

  2016cites this paper
• Etude multicentrique de nouveaux marqueurs tumoraux moléculaires dans les épanchements péritonéaux et le sang : analyse par PCR quantitative en temps réel

  2010cites this paper
• Facteurs pronostiques des carcinomes à cellules rénales aux stades localisés et métastatiques

  2009cites this paper
• [What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?].

  2008cites this paper
• Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.

  2008cites this paper